94 Ma and Yu: Global Burden of Cancer 9. WHO.int [homepage on the Internet]. Geneva, Switzerland: World Health Organi- zation. Media centre fact sheets [updated June 2005; cited April 2, 2007]. Available from: http://www.who.int/mediacentre/fact- sheets/fs292/en/ 10. WHO.int [homepage on the Internet]. World Health Organization. Press release: FAO/WHO: Amount of poor-quality pesti- cides sold in developing countries alarmingly high [2001 February 1; cited 2007 April 2]. Available from: http://www.who.int/inf-pr- 2001/en/pr2001-04.html. 11. Parkin DM. The global health burden of in- fection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44. 12. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the devel- opment of gastric cancer. N Engl J Med. 2001;345(11):784-9. 13. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: Sum- mary of a clinical research workshop. Hepa- tology. 2007;45(4):1056-75. 14. Magalhaes Queiroz DM, Luzza F. Epidemi- ology of Helicobacter pylori infection. Heli- cobacter. 2006;11 Suppl 1:1-5. 15. Stuver SO, Boschi-Pinto C, Trichopoulos D. Infection with hepatitis B and C viruses, so- cial class and cancer. IARC Sci Publ. 1997;138:319-24. 16. Ogden CL, Carroll MD, Curtin LR, McDow- ell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-55. 17. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and pro- posed mechanisms. Nat Rev Cancer. 2004;4(8):579-91. 18. Kahn SE, Hull RL, Utzschneider KM. Mecha- nisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-6. 19. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29(1):109-17. 20. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991- 2005. Br J Cancer. 2004;90(11):2157-66. 21. Kamangar F, Dores GM, Anderson WF. Pat- terns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in dif- ferent geographic regions of the world. J Clin Oncol. 2006;24(14):2137-50. 22. Institute of Medicine (U.S.) Committee on Cancer Control in Low- and Middle-Income Countries; Sloan FA, Gelband H, editors. Cancer control opportunities in low- and middle-income countries. Washington, DC: National Academies Press; 2007.